Semaglutide May Boost Taste Sensitivity Other taste-related changes also potentially seen with the GLP-1 agent in proof-of-concept study Jun 02, 2024
Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24 Percentage weight loss is in line with pivotal trial results using standard obesity thresholds May 31, 2024
How Many Ditch GLP-1 Drugs? More Weekly Insulin Data; Ozempic for Alcohol Use? News and commentary from the endocrinology world May 28, 2024
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Options "I'm having to jump through hoops to live," says one patient May 26, 2024
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials Also in TTHealthWatch: early diagnosis and treatment of COPD and asthma May 25, 2024 podcast
Nutrition Experts Call on Congress to Advance 'Food Is Medicine' Movement Produce prescriptions, medically tailored meals improve quality of life, cut costs, they say May 22, 2024
GLP-1 Agonist Scripts Jumped 600% for Teens, Young Adults Since 2020 Females accounted for most of the prescription fills May 22, 2024
Insufficient Sleep May Influence Cognition in Teens With Overweight and Obesity Restricted sleep did not have same effects on adolescents with less weight May 21, 2024
Endoscopic Ablation Reduces 'Hunger Hormone,' Yields Weight Loss in Early Trial First-in-human study targets ghrelin production with mucosal ablation as obesity treatment May 21, 2024
South Park Takes on Wegovy; Decapitated Doc's Killer Sentenced; Deadliest Superbugs Health news and commentary gathered by staff May 17, 2024
Obesity Mystery Solved: The Reversible Cause You Never Knew Can you guess what caused this patient's extreme weight gain? May 16, 2024
Smartphone-Based Lifestyle Interventions Result in Modest, Sustained Weight Loss Interventions important for patients with no access to medical or surgical treatments May 15, 2024
Obesity, Low Body Mass Linked to Mental Health Concerns in Adolescents Psychosomatic concerns also increased significantly from 2002 to 2018 May 15, 2024
Wegovy Perks Sustained for Years; Most Have 'CKM Syndrome'; New Adrenal Guidelines News and commentary from the endocrinology world May 14, 2024
Slow Responders to Zepbound Achieve Meaningful Weight Loss Eventually It can take 20 weeks to titrate to highest dose, researcher points out May 10, 2024
Ozempic Price Cut; Hypoparathyroidism Tx Fast Tracked; Halle Berry's Menopause Bill News and commentary from the endocrinology world May 07, 2024
Some Patients Suffered Psychiatric Issues After Ozempic Initiation Two case reports detailed suicidal ideation, mania in weeks following semaglutide initiation May 05, 2024
FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs Patents block competition and inflate prescription drug cost, says FTC chair May 01, 2024
Hypothalamic Obesity Tx; Weekly Insulin Under Review; Ozempic Price Investigation News and commentary from the endocrinology world Apr 30, 2024
Patients Hitting GLP-1 Plateaus? Here's How to Help Set expectations up front, and explore alternative approaches when necessary Apr 30, 2024
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise? Gym and diet food companies look to muscle in Apr 25, 2024
New T2D Guidelines; More Cushing's Relacorilant Data; Drug Shortages Rage On News and commentary from the endocrinology world Apr 23, 2024
Ozempic Hiatus Before Surgery: Is a Weeklong Pause Really Needed? Incidence of respiratory complications similar to other antidiabetic agents, claims data suggest Apr 22, 2024
Underweight, but Not Obesity, Linked to Glaucoma Progression Meanwhile, tobacco/alcohol use had no significant links to changes in retinal nerve fiber layer Apr 22, 2024
Time-Restricted Eating Tied to Modest Weight Loss Benefits appeared to come mainly from reduced caloric intake Apr 19, 2024
Tirzepatide Improves Sleep Apnea in Patients With Obesity, Drugmaker Says Topline results add yet another potential reason for use of dual GIP/GLP-1 receptor agonist Apr 18, 2024
Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs? News and commentary from the endocrinology world Apr 16, 2024
No Link Between GLP-1 Drugs and Suicide, Says European Regulator EMA announcement comes a few months after FDA's preliminary evaluation Apr 12, 2024
Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ Annual price of semaglutide would have to drop significantly to be comparable Apr 12, 2024
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
Type D Personality and Hypothyroidism; Infertility and eGFR; Fracture Algorithm News and commentary from the endocrinology world Apr 09, 2024
Doc Flung From Trailer Dies; Viral Hepatitis Deaths Rise; Suicidal Thoughts and GLPs Health news and commentary from around the Web gathered by staff Apr 09, 2024
Medicare Can Cover Anti-Obesity Drugs for Heart Disease -- But at What Cost? Intense demand coupled with high costs may place pressures on CMS for years to come Apr 08, 2024
Wegovy Helps HFpEF Patients With Diabetes Mellitus Weight and symptoms improved in STEP-HFpEF DM trial Apr 07, 2024
Weight-Loss Drug Zepbound Faces Supply Issues Following weight-loss indication, patients struggle to obtain tirzepatide Apr 02, 2024
Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes? News and commentary from the endocrinology world Apr 02, 2024
Man With Chainsaw Assaults Hospital Staff; Havana Syndrome Case; Ozempic at Costco Health news and commentary from around the Web gathered by staff Apr 02, 2024
GLP-1 Users May Have Increased Endoscopy-Related Aspiration Pneumonia Risk Overall incidence is still low, however Apr 01, 2024
Need 10,000 Daily Steps to Prevent Obesity? It May Depend on Genetics Current recommendations may underestimate activity needs for people with high genetic risk Mar 27, 2024
Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? News and commentary from the endocrinology world Mar 26, 2024
